EUVIMEDEUVIMED entdecken
Crossref

Research on Lung Cancer Classification Based on Multidimensional Hematological Indicators and Machine Learning Models

Fan Jia, Jianmin Xu, Lijun Zeng, Shixin Sun, Naxin Zheng, Wenwen Zheng, Ying Li, Chenran Du, Xiuyun Yin, Yuan Huang, Xuemei Yang, Fang Yuan und 2 weitere

Journal of Evidence-Based Medicine · 2026

DOI: 10.1111/jebm.70119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Evidence-Based Medicine, 2026. Verfasst von Fan Jia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Machine Learning. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate subtyping of lung cancer is crucial for developing personalized treatment plans and improving patient outcomes. This study established machine learning models for lung cancer subtyping by integrating multidimensional hematological indicators, offering advantages such as non‐invasiveness, repeatability, and the capability for dynamic disease monitoring. The study utilized data from 771 lung cancer patients for model construction and validation, and an additional 510 independent cases were collected to assess the clinical applicability of the models. Ten supervised learning algorithms were screened, ultimately identifying the XGBoost model as optimal for differentiating small cell lung cancer from non‐small cell lung cancer, and the Random Forest model as optimal for distinguishing lung squamous cell carcinoma from lung adenocarcinoma. In the independent clinical validation cohorts from two centers, these two models achieved accuracies of 95% and 91%, respectively, demonstrating good clinical applicability and serving as a valuable complement to pathological biopsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMachine LearningHumansRandom ForestBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleMaleMiddle AgedPredictive Learning ModelsAgedCarcinoma, Non-Small-Cell LungCarcinoma, Squamous Cell

Stichwörter der Autor:innen

differential diagnosishematological indicatorslung cancermachine learning

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

Zitieren

APA

Jia, F., Xu, J., Zeng, L., Sun, S., Zheng, N., Zheng, W., Li, Y., Du, C., Yin, X., Huang, Y., Yang, X., Yuan, F., Li, B., & Li, B. (2026). Research on Lung Cancer Classification Based on Multidimensional Hematological Indicators and Machine Learning Models. Journal of Evidence-Based Medicine. https://doi.org/10.1111/jebm.70119

Vancouver

Jia F, Xu J, Zeng L, Sun S, Zheng N, Zheng W, et al. Research on Lung Cancer Classification Based on Multidimensional Hematological Indicators and Machine Learning Models. Journal of Evidence-Based Medicine. 2026. doi:10.1111/jebm.70119

BibTeX
@article{Jia2026,
  author = {Jia, Fan and Xu, Jianmin and Zeng, Lijun and Sun, Shixin and Zheng, Naxin and Zheng, Wenwen and Li, Ying and Du, Chenran and Yin, Xiuyun and Huang, Yuan and Yang, Xuemei and Yuan, Fang and Li, Boan and Li, Bo},
  title = {Research on Lung Cancer Classification Based on Multidimensional Hematological Indicators and Machine Learning Models},
  journal = {Journal of Evidence-Based Medicine},
  year = {2026},
  doi = {10.1111/jebm.70119}
}
Kostenlos starten →